UK markets open in 2 hours 6 minutes

Innate Pharma S.A. (IPHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8000+0.0600 (+2.19%)
At close: 04:00PM EDT
2.8000 0.00 (0.00%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.7400
Open2.8700
Bid0.0000 x 1400
Ask0.0000 x 1000
Day's range2.8000 - 2.8800
52-week range2.0000 - 11.9500
Volume4,933
Avg. volume26,920
Market cap223.31M
Beta (5Y monthly)0.12
PE ratio (TTM)N/A
EPS (TTM)-0.6940
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.25
  • Business Wire

    Innate Pharma to Participate in Upcoming Investor Conference

    MARSEILLE, France, June 23, 2022--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that its investor relation team will participate in the following upcoming investor conference:

  • Business Wire

    Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer

    MARSEILLE, France, June 03, 2022--Innate Pharma announces IPH5201 Phase 2 study in lung cancer

  • Business Wire

    Outcome of Innate Pharma’s 2022 Annual General Meeting

    MARSEILLE, France, May 20, 2022--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting results of its shareholders at the Annual General Meeting ("AGM"), which took place on May 20, 2022, in Marseille. All resolutions were voted on in accordance with the Executive Board’s recommendations.